EXHIBIT 31.1

 

CERTIFICATION BY OFFICER

 

I, John Climaco, certify that:

 

1. I have reviewed this Amendment No. 1 to Form 10-K for the year ended December 31, 2024 of CNS Pharmaceuticals, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   

 

Date: April 30, 2025 By: /s/ John Climaco
    John Climaco
    Chief Executive Officer and President